Frontlight ResearchEarly access
Pancreatic cancer trials in France
117 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - Phase 2Taking peopleTrial evaluating the efficacy and the safety of FOLFIRINOX3 treatment in patients with unresectable locally advanced or metastatic pancreatic cancer in first line of chemotherapy
- Where
- Besancon Cedex, Chalon Sur Saone, Dijon, Reims
- Age
- 18 years and over
- People
- 90
- Run by
- Centr Georges Francois Leclerc
See details and how to join2023-505889-29-01 - No phaseTaking peopleEfficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
- Where
- Marseille
- Age
- 18 years and over
- People
- 100
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT06046794 - Phase 1/2Taking peopleProspective cohort involving repeated medical PET-CT imaging with a new radiotracer (FAPI)
- Where
- Saint-Cloud
- Age
- 18 years and over
- People
- 50
- Run by
- Institut Curie
See details and how to join2024-512467-31-00 - Phase 1/2CompletedPhase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
- Where
- Bordeaux, Dijon, Lille, Paris, Paris Cedex 12, Saint-Herblain Cedex, Suresnes, Toulouse Cedex 9, Villejuif
- Age
- 18 years and over
- People
- 26 worldwide
- Run by
- Merck Healthcare KGaA
See details and how to join2024-517819-74-00 - Phase 3Not yet taking people in FrancePhase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
- Where
- Bordeaux, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Pessac, Saint-Herblain Cedex, Villejuif
- Age
- 18 years and over
- People
- 281 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524928-21-00 - Phase 3Taking peopleA Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Where
- Brest, Chambray Les Tours, Dijon, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Paris, Pessac, Poitiers, Reims Cedex, Rennes Cedex, Toulouse Cedex 9, Villejuif
- Age
- 18 years and over
- People
- 239 worldwide
- Run by
- Incyte Corp.
See details and how to join2025-525009-18-00 - Phase 1/2Taking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Toulouse, Villejuif
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Paris
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- Angers, Bordeaux, Bron, Lille, Lyon, Montpellier, Nantes, Strasbourg
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - No phaseNot yet taking people in FrancePredicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative Immunity
- Where
- Marseille
- Age
- 18 years and over
- People
- 310
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT07827911 - No phaseTaking peoplePOP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric
- Where
- Dijon, Grenoble, Lille, Marseille, Reims, Rouen, Saint-Cloud, Saint-Herblain, St-Malo, Tours
- Age
- 18 years and over
- People
- 72
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT06275737 - Phase 1Taking peopleA phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
- Where
- Lyon, Marseille, Toulouse, Vandoeuvre Les Nancy Cedex
- Age
- 18 years and over
- People
- 62 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521702-18-00 - No phaseTaking peopleAssessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
- Where
- Nice
- Age
- 18 years to 75 years
- People
- 98
- Run by
- Centre Antoine Lacassagne
See details and how to joinNCT07429487 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Besançon, Levallois-Perret, Marseille, Neuilly, Paris
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseNot yet taking people in FranceReal-world Evaluation of Different Endoscopic Biliary Drainage Techniques in Patients With Jaundice of Biliopancreatic Malignant Origin
- Where
- Limoges, Lyon, Montpellier, Nîmes, Paris, Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 300
- Run by
- Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT07817602 - Phase 1Taking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Lyon, Marseille, Poitiers, St Herblain, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - No phaseTaking peopleAcupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients
- Where
- Amiens, Caen, Créteil, Grenoble, Lille, Nîmes, Paris, Saint-Cloud, Saint-Mandé, Villejuif
- Age
- 18 years and over
- People
- 182
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
See details and how to joinNCT05850130 - No phaseNot yet taking people in FranceEvaluating the Effectiveness of AIT in the Treatment of Pain Related to Pancreatic Cancer
- Where
- Paris
- Age
- 20 years and over
- People
- 40
- Run by
- Clinique Bizet
See details and how to joinNCT07733427 - Phase 1Taking peopleStudy to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
- Where
- Bordeaux, Reims
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Duke Street Bio Ltd
See details and how to joinNCT06458712 · EU 2023-508805-26-00 - No phaseTaking peopleCOsegregation of VARiants in Panel of Genes
- Where
- Amiens, Angers, Angoulême, Avignon, Bastia, Besançon, Bordeaux, Bourges, Brest, Caen, Chambéry, Clermont-Ferrand, Colmar, Dijon, Grenoble, La Rochelle, La Roche-sur-Yon, Le Havre, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Nîmes, Niort, Orléans, Paris, Poissy, Poitiers, Reims, Rennes, Rouen, Saint-Cloud, Saint-Etienne, Saint-Herblain, Strasbourg, Toulouse, Tours, Troyes, Valence, Vandœuvre-lès-Nancy, Villejuif
- Age
- 18 years and over
- People
- 11,000 worldwide
- Run by
- Institut Curie
See details and how to joinNCT01689584 - Phase 2Taking peoplePancreatic cancer first-line NALIRIFOX optimization with 5-FU maintenance and role of antibiotics and microbiota exploration in second-line treatment – A non-comparative, randomized phase II PANORAMIX GERCOR G-116 PRODIGE 105 study
- Where
- Angers, Besançon, Bordeaux, Calais, Clermont-Ferrand, Grenoble Cedex 9, Lille Cedex, Limoges, Lorient, Marseille, Paris, Paris Cedex 12, Pessac, Poitiers, Reims Cedex, Saint-Cloud, Saint-Mandé, Saint-Priest-en-Jarez, Strasbourg, Toulouse Cedex 9, Vandoeuvre Les Nancy_ Cedex, Villejuif Cedex, Villeurbanne Cedex
- Age
- 18 years and over
- People
- 142
- Run by
- Association Gercor
See details and how to join2024-517766-41-00 - Phase 2Taking peopleLuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor
- Where
- Bordeaux, Clermont-Ferrand, Marseille, Montpellier Cedex 5, Vandoeuvre Les Nancy
- Age
- 18 years and over
- People
- 36 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04939610 · EU 2023-508995-12-01 - No phaseTaking peopleSuperb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy
- Where
- Lyon
- Age
- 18 years and over
- People
- 150
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT07274657 - Phase 2Taking peopleFAPI-PET value for the initial screening of pancreatic and biliary cancers (FAPDIG Study)
- Where
- Lyon, Montpellier Cedex 5, Talence
- Age
- 18 years and over
- People
- 120
- Run by
- Centre Hospitalier Universitaire De Bordeaux
See details and how to join2024-517270-23-00